Premium
Clinical evaluation of MK‐185: A new hypolipidemic drug
Author(s) -
Sirtori Cesare,
Hurwitz Aryeh,
Sabih Khalid,
Azarnoff Daniel L.
Publication year - 1972
Publication title -
lipids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.601
H-Index - 120
eISSN - 1558-9307
pISSN - 0024-4201
DOI - 10.1007/bf02532594
Subject(s) - clinical chemistry , lipidology , drug , triglyceride , plasma levels , pharmacology , medicine , chemistry , cholesterol
A double‐blind crossover study in 11 patients suggests that MK‐185 may be a useful drug in lowering plasma triglyceride levels, whereas it has minimal effects on cholesterol levels. A good correlation between the hypouricemic and protein bound iodine lowering effects and plasma level of MK‐185 was seen. No correlation with the hypolipidemic effect was noted.